The lupus susceptibility locus Sle3 is not sufficient to accelerate atherosclerosis in lupus-susceptible low density lipoprotein receptor-deficient mice

Lupus

Volumn 19, Issue 1, 2010, Pages 34-42

  Wade, N S ^a   Stevenson, B G ^a   Dunlap, D S ^a   Major, A S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Autoimmunity; Oxidized low density lipoprotein; Systemic lupus erythematosus; T cell

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN; CHOLESTEROL; CYTOKINE; DOUBLE STRANDED DNA; GENE PRODUCT; LOW DENSITY LIPOPROTEIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; PROTEIN SLE3; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; AUTOIMMUNITY; BONE MARROW CELL; CELL TRANSFER; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; GENE LOCUS; GENETIC SUSCEPTIBILITY; HUMORAL IMMUNITY; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNOMODULATION; IRRADIATION; LIPOPROTEIN DEFICIENCY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH2 CELL;

ANIMALS; ANTIBODY FORMATION; ATHEROSCLEROSIS; CHROMOSOME MAPPING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED C57BL; RECEPTORS, LDL; T-LYMPHOCYTES;

EID: 74849136845     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309345785     Document Type: Article

References (40)

1. George J., Harats D., Gilburd B., Levy Y., Langevitz P., Shoenfeld Y. Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis. Lupus 1999 ; 8: 220-226.
2. Bacon PA, Stevens RJ, Carruthers DM, Young SP, Kitas GD Accelerated atherogenesis in autoimmune rheumatic diseases. Autoimmun Rev 2002 ; 1: 338-347.
3. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA The bimodal mortality pattern of systemic lupus erythematosus. Am J Med 1976 ; 60: 221-225.
4. Manzi S., Selzer F., Sutton-Tyrrell K., et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999 ; 42: 51-60.
5. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993 ; 362: 801-809.
6. Sherer Y., Tenenbaum A., Praprotnik S., et al. Autoantibodies to cardiolipin and beta-2-glycoprotein-I in coronary artery disease patients with and without hypertension. Cardiology 2002 ; 97: 2-5. (Pubitemid 34224920)
7. George J., Harats D., Shoenfeld Y. Autoimmunity in atherosclerosis. The role of autoantigens. Clin Rev Allergy Immunol 2000 ; 18: 73-86.
8. Petri M., Perez-Gutthann S., Spence D., Hochberg MC Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992 ; 93: 513-519.
9. Asanuma Y., Oeser A., Shintani AK, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003 ; 349: 2407-2415.
10. Frostegard J. SLE, atherosclerosis and cardiovascular disease. J Intern Med 2005 ; 257: 485-495.
11. Svenungsson E., Jensen-Urstad K., Heimburger M., et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001 ; 104: 1887-1893.
12. Morel L., Rudofsky UH, Longmate JA, Schiffenbauer J., Wakeland EK Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1994 ; 1: 219-229.
13. Morel L., Yu Y., Blenman KR, Caldwell RA, Wakeland EK Production of congenic mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm Genome 1996 ; 7: 335-339.
14. Morel L., Mohan C., Yu Y., et al. Functional dissection of systemic lupus erythematosus using congenic mouse strains. J Immunol 1997 ; 158: 6019-6028.
15. Mohan C., Alas E., Morel L., Yang P., Wakeland EK Genetic dissection of SLE pathogenesis. Sle1 on murine chromosome 1 leads to a selective loss of tolerance to H2A/H2B/DNA subnucleosomes. J Clin Invest 1998 ; 101: 1362-1372.
16. Sobel ES, Satoh M., Chen Y., Wakeland EK, Morel L. The major murine systemic lupus erythematosus susceptibility locus Sle1 results in abnormal functions of both B and T cells. J Immunol 2002 ; 169: 2694-2700.
17. Mohan C., Morel L., Yang P., Wakeland EK Genetic dissection of systemic lupus erythematosus pathogenesis: Sle2 on murine chromosome 4 leads to B cell hyperactivity. J Immunol 1997 ; 159: 454-465.
18. Mohan C., Yu Y., Morel L., Yang P., Wakeland EK Genetic dissection of Sle pathogenesis: Sle3 on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J Immunol 1999 ; 162: 6492-6502.
19. Zhu J., Liu X., Xie C., et al. T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest 2005 ; 115: 1869-1878.
20. Sobel ES, Morel L., Baert R., Mohan C., Schiffenbauer J., Wakeland EK Genetic dissection of systemic lupus erythematosus pathogenesis: evidence for functional expression of Sle3/5 by non-T cells. J Immunol 2002 ; 169: 4025-4032.
21. Stanic AK, Stein CM, Morgan AC, et al. Immune dysregulation accelerates atherosclerosis and modulates plaque composition in systemic lupus erythematosus. Proc Natl Acad Sci USA 2006 ; 103: 7018-7023.
22. Braun N., Wade N., Wakeland E., Major A. Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr-/- mice. Lupus 2008 ; 17: 1070-1078.
23. Liuzzo G., Kopecky SL, Frye RL, et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation 1999 ; 100: 2135-2139.
24. Jonasson L., Holm J., Skalli O., Bondjers G., Hansson GK Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 1986 ; 6: 131-138.
25. Fazio S., Major AS, Swift LL, et al. Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages. J Clin Invest 2001 ; 107: 163-171.
26. Shivakumar S., Tsokos GC, Datta SK T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. J Immunol 1989 ; 143: 103-112.
27. Major AS, Fazio S., Linton MF B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice. Arterioscler Thromb Vasc Biol 2002 ; 22: 1892-1898.
28. Gautier EL, Huby T., Ouzilleau B., et al. Enhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice. Arterioscler Thromb Vasc Biol 2007 ; 27: 1625-1631.
29. Zampieri S., Iaccarino L., Ghirardello A., et al. Systemic lupus erythematosus, atherosclerosis, and autoantibodies. Ann NY Acad Sci 2005 ; 1051: 351-361. (Pubitemid 41362765)
30. Westerweel PE, Luyten RK, Koomans HA, Derksen RH, Verhaar MC Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus. Arthritis Rheum 2007 ; 56: 1384-1396.
31. Paiker JE, Raal FJ, von Arb M. Auto-antibodies against oxidized LDL as a marker of coronary artery disease in patients with familial hypercholesterolaemia. Ann Clin Biochem 2000 ; 37: 174-178. (Pubitemid 30122241)
32. Wu JT, Wu LL Autoantibodies against oxidized LDL. A potential marker for atherosclerosis. Clin Lab Med 1997 ; 17: 595-604.
33. Kobayashi K., Tada K., Itabe H., et al. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages. Lupus 2007 ; 16: 929-938.
34. Hartvigsen K., Chang MK, et al. IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis. J Clin Invest 2004 ; 114: 427-437.
35. Shaw PX, Horkko S., Chang MK, et al. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 2000 ; 105: 1731-1740.
36. Lambert SL, Okada CY, Levy R. TCR vaccines against a murine T cell lymphoma: a primary role for antibodies of the IgG2c class in tumor protection. J Immunol 2004 ; 172: 929-936.
37. Finkelman FD, Katona IM, Mosmann TR, Coffman RL IFNgamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 1988 ; 140: 1022-1027.
38. Hansson GK Immune mechanisms in atherosclerosis. Arterioscler Thromb Vasc Biol 2001 ; 21: 1876-1890.
39. Zhou X., Nicoletti A., Elhage R., Hansson GK Transfer of CD4+ T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000 ; 102: 2919-2922.
40. Zhou X., Robertson AK, Hjerpe C., Hansson GK Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis. Arterioscler Thromb Vasc Biol 2006 ; 26: 864-870.